The UNLV Rebels greatly boosted their defense as standout cornerback Denver Harris announced his transfer to Las Vegas via the NCAA Transfer Portal. A former fi ...

The roster overhaul continues for the UNLV Rebels and head coach Dan Mullen. Since being hired to take over the Mountain West program on Dec. 12, Mullen and his staff have been very busy in the ...

Former Michigan quarterback Alex Orji is joining the UNLV football team, he confirmed Saturday via social media. In three years with the Wolverines, he played in 20 games (three starts), throwing ...

For each game he broadcasts during the 2024 NFL season all the way through Super Bowl LIX, FOX Sports lead NFL analyst Tom Brady is awarding his LFG Player of the Game to that one player he sees ...

UNLV Football has taken another significant ... The announcement, made Thursday, highlights Mullen’s commitment to building a top-tier support staff for the Rebels. Davis brings a wealth of ...

One thing was conspicuously missing during UNLV’s 84-62 loss at Colorado State on Saturday: a comeback attempt. The Scarlet and Gray trailed by double digits for almost the entire second half ...

Dan Mullen added a second veteran quarterback on Saturday as Michigan transfer Alex Orji committed to UNLV. Orji is a 6-foot-3, 235-pound senior who comes to the Scarlet and Gray with two years of ...

"A lot of momentum is building for Pete Carroll," Bonsignore posted on X. "In many ways, he is exactly what they need right now. Likely with a protegee/successor that comes on board with him." ...

The behavior of massive wildland fires is incredibly complex, but as the western U.S. experiences these events with increasing frequency, the need to better understand those systems has become crucial ...

"LCCI Hyderabad will focus on scaling up Lilly's innovation and efficiency by unlocking new technological advancements and leveraging data insights, accelerating the delivery of next-generation ...

Eli Lilly's operational performance is strong, but shares are expensive, leading me to reaffirm a 'hold' rating despite potential upside from new drugs. Recent financial results show significant ...